Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and ...

Special Report: PainChek, the developer of a smart device-based pain assessment and monitoring application, has established ...

A YouGov survey found 70 per cent of women and 52 per cent of men have felt dismissed or unheard by a GP. The fact more women ...

Pain is hard to measure. One person’s “ouch” is another’s agony. Now, scientists say they’ve found a better way of assessing ...

The question will no longer be whether we can trust AI; it will become whether AI can enhance trust between patients and ...

The risk for dementia was significantly higher in those with prefrailty and frailty compared with nonfrail individuals.

High-impact pain strongly predicts subjective cognitive decline in older adults. For objective impairment, risk is distinct for APOE4 carriers vs non-carriers.

Asking people how much money they would accept to experience pain again can provide a more accurate and comparable measure of ...

Imagine if there were a tech device that could substantially decrease your chances of developing dementia or Alzheimer’s disease. Would you be interested in using it?